Search research articles
Contact Us
Filters
Showing results (641-650 of 758) with videos related to
Page
of 76
Sort By:
Nature Methods
|
November 1, 2018
Engineered anti-CRISPR proteins for optogenetic control of CRISPR-Cas9
Felix Bubeck, Mareike D Hoffmann, Zander Harteveld, et al.
International Journal of Radiation Biology
|
December 9, 2008
First human treatment of resistant neoplastic meningitis by intrathecal administration of MTX plus (125)IUdR
C Rebischung, D Hoffmann, L Stefani, et al.
Cell Reports
|
June 18, 2023
ETV2 primes hematoendothelial gene enhancers prior to hematoendothelial fate commitment
Jeffrey D Steimle, Chul Kim, Megan Rowton, et al.
JAMA
|
August 6, 2000
Health risks associated with cigar smoking
F Baker, S R Ainsworth, J T Dye, et al.
Nature Chemical Biology
|
April 15, 2020
Computational design of anti-CRISPR proteins with improved inhibition potency
Jan Mathony, Zander Harteveld, Carolin Schmelas, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 21, 2020
Hedgehog-FGF signaling axis patterns anterior mesoderm during gastrulation
Alexander Guzzetta, Mervenaz Koska, Megan Rowton, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
April 19, 2018
A cluster of two human cases of tick-borne encephalitis (TBE) transmitted by unpasteurised goat milk and cheese in Germany, May 2016
S O Brockmann, R Oehme, T Buckenmaier, et al.
Human Gene Therapy
|
August 14, 2019
Capsid Engineering Overcomes Barriers Toward Adeno-Associated Virus Vector-Mediated Transduction of Endothelial Cells
L Zhang, A Rossi, L Lange, et al.
Nature Communications
|
March 29, 2025
β-Carotene alleviates substrate inhibition caused by asymmetric cooperativity
Jieren Liao, Umar F Shahul Hameed, Timothy D Hoffmann, et al.
Infection
|
February 2, 2024
Clinical and immunological outcomes of SARS-CoV-2-infected vaccine responders, vaccine non-responders, and unvaccinated patients evaluated for neutralizing monoclonal antibody treatment at a single German tertiary care center: a retrospective cohort study with prospective follow-up
J Triebelhorn, J Schneider, C D Spinner, et al.
Page
of 76
Search research articles
Search
Showing results (641-650 of 758) with videos related to
Sort By:
Page
of 76
Nature Methods
|
November 1, 2018
Engineered anti-CRISPR proteins for optogenetic control of CRISPR-Cas9
Felix Bubeck, Mareike D Hoffmann, Zander Harteveld, et al.
International Journal of Radiation Biology
|
December 9, 2008
First human treatment of resistant neoplastic meningitis by intrathecal administration of MTX plus (125)IUdR
C Rebischung, D Hoffmann, L Stefani, et al.
Cell Reports
|
June 18, 2023
ETV2 primes hematoendothelial gene enhancers prior to hematoendothelial fate commitment
Jeffrey D Steimle, Chul Kim, Megan Rowton, et al.
JAMA
|
August 6, 2000
Health risks associated with cigar smoking
F Baker, S R Ainsworth, J T Dye, et al.
Nature Chemical Biology
|
April 15, 2020
Computational design of anti-CRISPR proteins with improved inhibition potency
Jan Mathony, Zander Harteveld, Carolin Schmelas, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 21, 2020
Hedgehog-FGF signaling axis patterns anterior mesoderm during gastrulation
Alexander Guzzetta, Mervenaz Koska, Megan Rowton, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
April 19, 2018
A cluster of two human cases of tick-borne encephalitis (TBE) transmitted by unpasteurised goat milk and cheese in Germany, May 2016
S O Brockmann, R Oehme, T Buckenmaier, et al.
Human Gene Therapy
|
August 14, 2019
Capsid Engineering Overcomes Barriers Toward Adeno-Associated Virus Vector-Mediated Transduction of Endothelial Cells
L Zhang, A Rossi, L Lange, et al.
Nature Communications
|
March 29, 2025
β-Carotene alleviates substrate inhibition caused by asymmetric cooperativity
Jieren Liao, Umar F Shahul Hameed, Timothy D Hoffmann, et al.
Infection
|
February 2, 2024
Clinical and immunological outcomes of SARS-CoV-2-infected vaccine responders, vaccine non-responders, and unvaccinated patients evaluated for neutralizing monoclonal antibody treatment at a single German tertiary care center: a retrospective cohort study with prospective follow-up
J Triebelhorn, J Schneider, C D Spinner, et al.
Page
of 76